EUVIMEDEUVIMED entdecken
Crossref

Prognostic and predictive value of phospho-c-Jun expressionin hepatocellular carcinoma patients treated with sorafenib

Ergin Aydemir, Mehmet Arda İnan, Bediz Kurt İnci, Güldal Esendağlı, Aytuğ Üner

Annals of Clinical and Analytical Medicine · 01.05.2026 · 17 (5) · 472-477

DOI: 10.4328/acam.22838 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Analytical Medicine, erschienen am 01.05.2026. Verfasst von Ergin Aydemir und 4 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Hepatocellular carcinoma (HCC) is a highly lethal malignancy with limited treatment options at advanced stages. Sorafenib, a multikinase inhibitor, remains a key systemic therapeutic agent; however, treatment response varies significantly among patients. This study aimed to investigate phospho-c-Jun (PCJ) expression as a potential biomarker for sorafenib resistance and its association with survival outcomes in HCC patients.

Methods

This retrospective study analyzed 32 HCC patients who received first-line sorafenib therapy between September 2020 and January 2021. Immunohistochemical analysis was performed to determine nuclear phospho-c-Jun expression levels. Patients were categorized based on H-score (≥87.5 vs

Zitieren

APA

Aydemir, E., İnan, M. A., İnci, B. K., Esendağlı, G., & Üner, A. (2026). Prognostic and predictive value of phospho-c-Jun expressionin hepatocellular carcinoma patients treated with sorafenib. Annals of Clinical and Analytical Medicine, 17(5), 472-477. https://doi.org/10.4328/acam.22838

Vancouver

Aydemir E, İnan MA, İnci BK, Esendağlı G, Üner A. Prognostic and predictive value of phospho-c-Jun expressionin hepatocellular carcinoma patients treated with sorafenib. Annals of Clinical and Analytical Medicine. 2026;17(5):472-477. doi:10.4328/acam.22838

BibTeX
@article{Aydemir2026,
  author = {Aydemir, Ergin and İnan, Mehmet Arda and İnci, Bediz Kurt and Esendağlı, Güldal and Üner, Aytuğ},
  title = {Prognostic and predictive value of phospho-c-Jun expressionin hepatocellular carcinoma patients treated with sorafenib},
  journal = {Annals of Clinical and Analytical Medicine},
  year = {2026},
  volume = {17},
  number = {5},
  pages = {472--477},
  doi = {10.4328/acam.22838}
}
Kostenlos starten →